Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-03

Clinical Trial Update: Ketamine and Levetiracetam as Second-line Antiseizure Medication for Status Epilepticus in Children [Phase 2, Phase 3]

View source ↗

Summary

A pediatric clinical trial is evaluating ketamine and levetiracetam as second-line antiseizure medications for generalized convulsive status epilepticus, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Sohag University | Conditions: Generalized Convulsive Status Epilepticus | Phase 2, Phase 3 | Status: RECRUITING